0
Longeveron Inc. Banner Image

Longeveron Inc.

  • Ticker LGVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Longeveron Inc. Logo Image
  • 11-50 Employees
  • Based in Miami, Florida
Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™ an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B™ has multiple mechanisms of action encompassing pro-vascular, pro-regenerativeMore, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently advancing Lomecel-B™ through clinical trials in three indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s Disease, and Aging-Related Frailty.
Longeveron Inc.

Most Recent Annual Report

Longeveron Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Longeveron Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!